UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported):  November 27, 2015

 

MedeFile International, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Nevada	033-25126 D	85-0368333
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

 

301 Yamato Road Suite 1200 Boca Raton, FL	33431
(Address of principal executive offices)	(Zip Code)

 

Registrant’s telephone number, including area code: (561) 912-3393

 

(Former name or former address, if changed since last report)

Copies to: Richard A. Friedman, Esq. Jeff Cahlon, Esq. Sichenzia Ross Friedman Ference LLP 61 Broadway, 32nd Floor New York, New York 10006 Telephone: (212) 930-9700

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

 

On November 27, 2015, the board of directors of MedeFile International, Inc. (the “Company”), concluded that the Company’s previously issued financial statements, for the periods ended March 31, 2015 and June 30, 2015, should no longer be relied upon because of an error in such financial statements. Specifically, the Company did not account for a derivative under a convertible note in accordance with Accounting Standards Codification (ASC) 815, Derivatives and Hedging, in these financial statements. The Company expects to file its restated financial statements for the periods ended March 31, 2015 and June 30, 2015 as soon as practicable. Niquana Noel, the Company’s chief executive officer, has discussed this matter with the Company’s independent accountant.

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

	MEDEFILE INTERNATIONAL, INC.
Date: December 7, 2015	By:	/s/  Niquana Noel
		Name:  Niquana Noel
		Title: Chief Executive Officer